118 related articles for article (PubMed ID: 2308675)
1. The effects of anesthesia on osmotic blood-brain barrier disruption.
Gumerlock MK; Neuwelt EA
Neurosurgery; 1990 Feb; 26(2):268-77. PubMed ID: 2308675
[TBL] [Abstract][Full Text] [Related]
2. The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.
Remsen LG; Pagel MA; McCormick CI; Fiamengo SA; Sexton G; Neuwelt EA
Anesth Analg; 1999 Mar; 88(3):559-67. PubMed ID: 10072006
[TBL] [Abstract][Full Text] [Related]
3. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
[TBL] [Abstract][Full Text] [Related]
5. A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine.
Fortin D; Adams R; Gallez A
Can J Neurol Sci; 2004 May; 31(2):248-53. PubMed ID: 15198452
[TBL] [Abstract][Full Text] [Related]
6. Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia.
Chi OZ; Liu X; Weiss HR
Anesthesiology; 2001 Oct; 95(4):933-8. PubMed ID: 11605935
[TBL] [Abstract][Full Text] [Related]
7. Electroencephalographic consequences of sodium dehydrocholate-induced blood-brain barrier disruption: Part 1. Acute and chronic effects of intracarotid sodium dehydrocholate.
Zappulla RA; Spigelman MK; Omsberg E; Rosen JJ; Malis LI; Holland JF
Neurosurgery; 1985 May; 16(5):630-8. PubMed ID: 4000434
[TBL] [Abstract][Full Text] [Related]
8. The effects of morphine on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lee DI; Liu X; Weiss HR
Anesth Analg; 2000 Mar; 90(3):603-8. PubMed ID: 10702444
[TBL] [Abstract][Full Text] [Related]
9. Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.
Fortin D; McCormick CI; Remsen LG; Nixon R; Neuwelt EA
Neurosurgery; 2000 Jul; 47(1):199-207. PubMed ID: 10917363
[TBL] [Abstract][Full Text] [Related]
10. Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia.
Krysl D; Deykun K; Lambert L; Pokorny J; Mares J
J Physiol Pharmacol; 2012 Apr; 63(2):127-32. PubMed ID: 22653898
[TBL] [Abstract][Full Text] [Related]
11. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
12. Intracarotid hypothermic saline infusion: a new method for reversible blood-brain barrier disruption in anesthetized rats.
Oztaş B; Küçük M
Neurosci Lett; 1995 May; 190(3):203-6. PubMed ID: 7637893
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
[TBL] [Abstract][Full Text] [Related]
14. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study.
Salahuddin TS; Johansson BB; Kalimo H; Olsson Y
Neuropathol Appl Neurobiol; 1988; 14(6):467-82. PubMed ID: 3147406
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.
Cosolo WC; Martinello P; Louis WJ; Christophidis N
Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773
[TBL] [Abstract][Full Text] [Related]
16. Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.
Martin JA; Maris AS; Ehtesham M; Singer RJ
J Vis Exp; 2012 Nov; (69):e50019. PubMed ID: 23222697
[TBL] [Abstract][Full Text] [Related]
17. Osmotic opening of the blood-brain barrier and local cerebral glucose utilization.
Pappius HM; Savaki HE; Fieschi C; Rapoport SI; Sokoloff L
Ann Neurol; 1979 Mar; 5(3):211-9. PubMed ID: 443753
[TBL] [Abstract][Full Text] [Related]
18. Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.
Spigelman MK; Zappulla RA; Johnson J; Goldsmith SJ; Malis LI; Holland JF
J Neurosurg; 1984 Oct; 61(4):674-8. PubMed ID: 6470777
[TBL] [Abstract][Full Text] [Related]
19. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
Brown RC; Egleton RD; Davis TP
Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
[TBL] [Abstract][Full Text] [Related]
20. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study.
Salahuddin TS; Johansson BB; Kalimo H; Olsson Y
Acta Neuropathol; 1988; 77(1):5-13. PubMed ID: 3149121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
